Pharmaceutical Technology

JUNE 10, 2023

CIGB-128 is under clinical development by Center for Genetic Engineering and Biotechnology and currently in Phase I for Brain Tumor. According to GlobalData, Phase I drugs for Brain Tumor does not have sufficient historical data to build an indication benchmark PTSR for Phase I.

Genetic Engineering 100

Genetic Engineering Engineer Genetics Clinical Trials 100

Pharmaceutical Technology

JUNE 10, 2023

CIGB-128 is under clinical development by Center for Genetic Engineering and Biotechnology and currently in Phase I for Brain Tumor. According to GlobalData, Phase I drugs for Brain Tumor does not have sufficient historical data to build an indication benchmark PTSR for Phase I.

Genetic Engineering 100

Genetic Engineering Engineer Genetics Clinical Trials 100

Bio Pharma Dive

MARCH 20, 2024

million list price, the highest of any genetic medicine to come to market. Orchard is counting on the long-term data it’s accrued to convince insurers to cover Lenmeldy’s $4.25

Gene Therapy 194

Gene Therapy Gene Genetics Medicine 194

pharmaphorum

JANUARY 24, 2023

Ben Hargreaves finds that the vast amount of genetic data that exists today could help provide a faster, more targeted way of developing new drug candidates. The logical extension to this kind of approach is treating individual patients, with their individual genetic makeup.

Genetics 95

Genetics Drugs Genome Project Biobanking 95

BioSpace

APRIL 11, 2024

and Canadian markets, Amylyx is now charting a path in Wolfram syndrome with promising interim Phase II data for its lead asset AMX0035. On the heels of withdrawing Relyvrio from the U.S.

Genetic Disease 108

Genetic Disease Genetics Marketing 108

BioPharma Reporter

JANUARY 25, 2024

Genetic Design and Manufacturing Corporation (GDMC) has bagged $21 million in Series A funding to accelerate its next-gen advanced genetic therapies.

Genetics 52

Genetics Manufacturing Regulation Marketing 52

Bio Pharma Dive

JULY 21, 2021

The approval of Skysona for a genetic brain disease is a milestone for one of gene therapy's pioneering companies, but isn't expected to turn Bluebird's financial fortunes around.

Gene Therapy 300

Gene Therapy Gene Genetics Marketing 300

Scienmag

DECEMBER 16, 2020

News from the Journal of Marketing Researchers from The Wharton School of the University of Pennsylvania published a new paper in the Journal of Marketing that assesses the implications of the growth of private genetic testing for the field of marketing and evaluates ethical challenges that arise.

Genetics 40

Genetics Marketing Research Gene 40

Roots Analysis

JUNE 1, 2022

DNA Cloning Kit Providers – Current Market Landscape. The market is highly fragmented, featuring the presence of both new entrants and established players, based in different geographical regions. DNA Cloning Kits Market. DNA Cloning Reagent Providers – Current Market Landscape. DNA Cloning Reagents Market.

DNA 52

DNA Genetics Reagent Marketing 52

Pharmaceutical Technology

NOVEMBER 2, 2022

The European Medicines Agency (EMA) has granted full marketing authorisation (MA) for AstraZeneca ’s Covid-19 vaccine, Vaxzevria (ChAdOx1-S [Recombinant]). The vaccine initially received a conditional marketing authorisation (cMA) for use in the European Union (EU).

Vaccination 147

Vaccination Vaccine Marketing Clinical Trials 147

BioTech 365

AUGUST 24, 2021

Global Direct to Consumer Genetic Testing Market to 2027 – ResearchAndMarkets.com Global Direct to Consumer Genetic Testing Market to 2027 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Global Direct to Consumer Testing Market to 2027” report has been added to ResearchAndMarkets.com’s offering.

Genetics 40

Genetics Marketing 40

BioTech 365

AUGUST 19, 2021

Achromatopsia (Genetic Disorders) Drugs in Development, 2021 Market Research Report – ResearchAndMarkets.com Achromatopsia (Genetic Disorders) Drugs in Development, 2021 Market Research Report – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Achromatopsia (Genetic Disorders) – Drugs in Development, 2021” (..)

Genetics 40

Genetics Marketing Development Research 40

BioTech 365

JUNE 4, 2021

Global Genetic Testing (Equipment & Consumables) Market 2021-2025: Rising Approval of Advanced Genetic Testing Products and Increasing Affordability – ResearchAndMarkets.com Global Genetic Testing (Equipment & Consumables) Market 2021-2025: Rising Approval of Advanced Genetic Testing Products and Increasing Affordability – ResearchAndMarkets.com (..)

Genetics 40

Genetics Production Marketing 40

BioTech 365

NOVEMBER 29, 2021

Europe Hereditary Genetic Testing Market Report 2021: Focus on Products, Sample Type, Applications – ResearchAndMarkets.com Europe Hereditary Genetic Testing Market Report 2021: Focus on Products, Sample Type, Applications – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Europe Hereditary Genetic Testing Market Analysis (..)

Genetics 40

Genetics Production Marketing 40

XTalks

JULY 19, 2021

Phosphorus, a leading preventative genomics company, has developed the first comprehensive preventative genetic test for consumers. The test is called GeneCompass and features medical-grade technology to provide a holistic assessment of genetic health and wellness. The Phosphorus GeneCompass test has a list price of $249.

Genetics 98

Genetics Genome Genomics Gene 98

BioTech 365

FEBRUARY 1, 2021

Cancer Genetics Announces Closing of $10.0 Million Private Placement Priced At-the-Market Cancer Genetics Announces Closing of $10.0 Million Private Placement Priced At-the-Market RUTHERFORD, N.J., 01, 2021 (GLOBE NEWSWIRE) — Cancer Genetics, Inc.

Genetics 40

Genetics Marketing Drugs 40

BioTech 365

SEPTEMBER 4, 2020

LONDON–(BUSINESS WIRE)–#GeneticTestingMarket–Technavio has been monitoring the genetic testing market and it is poised to grow by USD 4.86 billion during 2020-2024, progressing at a CAGR of over 12% during the forecast period. The report offers an up-to-date analysis regarding the … Continue reading →

Genetics 52

Genetics Marketing Production 52

Pharmaceutical Technology

SEPTEMBER 20, 2022

The production of commercial dose non-sterile products such as tablets, capsules, ointments, creams, and powders is rising due to their growing global demand, attributed to increasing demand for anti-ageing products, hereditary factors, genetic mutations, exposure to harmful radiation, and rising geriatric population.

Marketing 130

Marketing Drug Delivery Systems Production Containment 130

BioTech 365

DECEMBER 14, 2021

Insights on the Marine Pharmaceuticals Global Market to 2026 – Featuring GlaxoSmithKline, Seattle Genetics, PharmaMar and Jazz Pharmaceuticals – ResearchAndMarkets.com Insights on the Marine Pharmaceuticals Global Market to 2026 – Featuring GlaxoSmithKline, Seattle Genetics, PharmaMar and Jazz Pharmaceuticals – ResearchAndMarkets.com (..)

Genetics 40

Genetics Marketing 40

BioTech 365

FEBRUARY 10, 2021

Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules RUTHERFORD, N.J., 10, 2021 (GLOBE NEWSWIRE) — Cancer Genetics, Inc.

Genetics 40

Genetics Marketing 40

Pharma Mirror

MAY 7, 2021

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical, has expanded its gene technology clinical trial services to meet the increasing global demand predicted to reach $17.4 billion Market Demand appeared first on Pharma Mirror Magazine. billion by 2023.

Clinical Trials 130

Clinical Trials Clinical Trials Gene Marketing 130

pharmaphorum

AUGUST 10, 2021

Europe market has proved so hostile to gene therapies when it comes to pricing and reimbursement for gene therapies that bluebird bio has decided to quit the market altogether, according to Andrew Obenshain, president of its severe genetic diseases unit. market and will wind down in Europe.

Gene Therapy 135

Gene Therapy Gene Marketing Genetic Disease 135

BioTech 365

MAY 31, 2021

Global Regenerative Medicine Market to 2030 – Rising Prevalence of Chronic Diseases and Genetic Disorders are Driving Growth – ResearchAndMarkets.com Global Regenerative Medicine Market to 2030 – Rising Prevalence of Chronic Diseases and Genetic Disorders are Driving Growth – ResearchAndMarkets.com … Continue reading → (..)

Genetics 40

Genetics Medicine Marketing 40

Roots Analysis

JANUARY 19, 2024

Introduction In a strategic move to accelerate the development and launch of genetic medicines, BridgeBio Pharma has successfully secured up to USD 1.25 Billion to Propel Genetic Medicine Development appeared first on Blog. billion from Blue Owl Capital and Canada Pension Plan Investment Board. With a cash position of USD 505.2

Genetics 40

Genetics Medicine Development Protein 40

Drug Discovery World

FEBRUARY 20, 2024

The drug discovery informatics market is predicted to grow from $3.77 Drug discovery informatics trends The increasing prevalence of chronic diseases is anticipated to play a large part in driving the expansion of the informatics market. The post Drug discovery informatics market predicted to grow 12.6% billion in 2024 to $6.06

Marketing 52

Marketing Drugs Life Science Genome 52

BioTech 365

JUNE 27, 2021

Eurofins to Acquire DNA Diagnostics Center to Grow Genetic Testing Capabilities and Significantly Expand Further Into the Consumer Testing Market Eurofins to Acquire DNA Diagnostics Center to Grow Genetic Testing Capabilities and Significantly Expand Further Into the Consumer Testing Market … Continue reading →

DNA 52

DNA Genetics Marketing 52

AuroBlog - Aurous Healthcare Clinical Trials blog

JUNE 8, 2023

The artificial sweetener sucralose (marketed as Splenda) is widely used and found in products like diet soda and chewing gum. As DNA holds the genetic code controlling how our bodies grow and are maintained, that’s a serious problem that […]

DNA 196

DNA Scientist Genetics Production 196

Scienmag

JANUARY 14, 2022

These insect-specific chemicals, which cost more than $100 million to develop and bring to market, also are critical to controlling insect-driven crop damage that poses a challenge to food security. […].

Genetics 87

Genetics Marketing Development Engineer 87

Pharma Marketing Network

DECEMBER 21, 2020

Almost two decades after the human genome was sequenced, a trickle of new genetic medicines (i.e., A herculean effort will be required from pharmaceutical marketers of all stripes, but particularly those in the promotional medical education (promo med-ed) space, to address the many challenges.

Genetics 52

Genetics Medicine Gene Therapy Marketing 52

BioTech 365

APRIL 9, 2021

Global Genetic Testing Market Applications and Technologies Report 2021-2025: COVID-19 Pandemic Impact Updates with Executive and Consultant Guides – ResearchAndMarkets.com Global Genetic Testing Market Applications and Technologies Report 2021-2025: COVID-19 Pandemic Impact Updates with Executive and Consultant Guides – ResearchAndMarkets.com (..)

Genetics 40

Genetics Marketing 40

BioTech 365

OCTOBER 16, 2020

DUBLIN–(BUSINESS WIRE)–The “The Global Genetic Testing Market by Hereditary, Newborn, NIPT, Oncology, Pharmacogenomic and Direct to Consumer, With Executive and Consultant Guides 2020 to 2024” report has been added to ResearchAndMarkets.com’s offering.

Genetics 40

Genetics Marketing Genome Genomics 40

Roots Analysis

NOVEMBER 5, 2023

Over time, extensive research in liquid biopsy market has resulted in the recognition of minimally invasive liquid biopsies as a viable technique for cancer detection. Tumor Heterogeneity: Cancer is known for its genetic heterogeneity, meaning different regions of a tumor can have distinct genetic profiles.

Marketing 40

Marketing Genetics DNA Research 40

Outsourcing Pharma

DECEMBER 1, 2022

ALS genetic carrier finds value in EverythingALS study leveraging digital biomarkers as a means to create tools for early detection of ALS and potentially other neurological diseases.

Genetics 59

Genetics Clinical Research Research Regulation 59

BioTech 365

DECEMBER 20, 2021

Genome Editing/Genome Engineering Market Research Report 2021: Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics) – ResearchAndMarkets.com Genome Editing/Genome Engineering Market Research Report 2021: Technology (CRISPR, TALEN, ZFN, Antisense), Product & (..)

Genetic Engineering 40

Genetic Engineering Engineer Genome Genomics 40

BioPharma Reporter

AUGUST 8, 2023

Sano Genetics, a Cambridge-based company accelerating precision medicine research, has secured a Â330K grant from Innovate UK.

Genetics 52

Genetics Medicine Research Regulation 52

BioTech 365

DECEMBER 3, 2020

RNAi Technology Market- by Application (Cancer, Infectious Diseases, Ophthalmic Diseases, Genetic Diseases, and Other Diseases) and by Region – Global Forecasts 2020-2024 | Technavio RNAi Technology Market- by Application (Cancer, Infectious Diseases, Ophthalmic Diseases, Genetic Diseases, and Other Diseases) and … Continue reading (..)

Genetic Disease 40

Genetic Disease Genetics Marketing 40

STAT News

APRIL 3, 2023

On Monday, Vertex Pharmaceuticals and its partner CRISPR Therapeutics said they had met their previously announced goal of filing by the end of March a marketing application for their therapy known as exa-cel.

Genetics 131

Genetics Gene Therapy Gene Manufacturing 131